ctrl K

Price Alert

NovaBay Pharmaceuticals I... (NBY)

AMEX: NBY · Real-Time Price · USD

0.98

0.38 (63.33%)

At close: Aug 20, 2025, 1:29 PM

NovaBay Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	430K	3.13M	5.36M	7.5M
Short-Term Investments	n/a	n/a	n/a	n/a
Long-Term Investments	477K	n/a	484K	475K
Other Long-Term Assets	3K	497K	489K	476K
Receivables	389K	759K	1.97M	1.67M
Inventory	765K	2.88M	3.44M	3.22M
Other Current Assets	158K	81K	159K	129K
Total Current Assets	1.94M	7.15M	11.33M	13.17M
Property-Plant & Equipment	1.01M	1.38M	1.95M	604K
Goodwill & Intangibles	n/a	n/a	2.63M	9.73M
Total Long-Term Assets	1.49M	1.88M	5.07M	10.81M
Total Assets	3.42M	9.03M	16.4M	23.98M
Account Payables	623K	1.13M	1.08M	1.04M
Deferred Revenue	488K	n/a	1.81M	1.29M
Short-Term Debt	565K	1.14M	453K	305K
Other Current Liabilities	172K	1.18M	406K	320K
Total Current Liabilities	2.84M	4.28M	4.26M	3.44M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	334K	n/a	10.12M
Total Long-Term Liabilities	709K	1.44M	1.59M	10.37M
Total Liabilities	3.55M	5.72M	5.84M	13.81M
Total Debt	1.67M	2.74M	2.04M	551K
Common Stock	49K	112K	652K	478K
Retained Earnings	-183.46M	-174.85M	-158.15M	-141.89M
Comprehensive Income	n/a	n/a	n/a	n/a
Shareholders Equity	-129K	3.31M	10.55M	10.17M
Total Investments	477K	476K	484K	475K